Antinuclear antibodies (ANAs) are a diverse group of autoantibodies that recognize nuclear
macromolecules and their complexes. ANAs represent key biomarkers in the evaluation of …

Antinuclear antibodies (ANAs) are valuable laboratory markers to screen for and support the
diagnosis of various rheumatic diseases (known as ANA-associated rheumatic diseases) …

Antinuclear antibodies (ANAs) are venerable biomarkers for assessing the diagnosis and
prognosis of patients with autoimmunity. While closely associated with diseases such as …

Testing for the presence of antinuclear antibodies (ANAs) is a key step in the diagnosis of
systemic lupus erythematosus (SLE) and other systemic autoimmune rheumatic diseases …

Objective The expression of antinuclear antibodies (ANA) is considered almost constant in
systemic lupus erythematosus (SLE), although recent experience has suggested that many …

Anti-nuclear antibodies (ANA) are fundamental for the diagnosis of autoimmune diseases,
and have been determined by indirect immunofluorescence assay (IIFA) for decades. As the …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by
antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by …

The detection of autoantibodies that target intracellular antigens, commonly termed anti‐
nuclear antibodies (ANA), is a serological hallmark in the diagnosis of systemic autoimmune …

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by
antinuclear antibody (ANA) production. ANAs bind to DNA, RNA and complexes of proteins …

Autoantibodies have been regarded as a serologic hallmark of systemic autoimmune
rheumatic diseases (ARDs) for more than half a century. Two years following the landmark …